已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Score-based immunoglobulin G therapy of patients with sepsis: The SBITS study*

医学 安慰剂 败血症 内科学 临床终点 机械通风 不利影响 临床试验 替代医学 病理
作者
Karl Werdan,Günter Pilz,Oskar Bujdoso,Peter Fraunberger,G. Neeser,Roland E. Schmieder,Burkhard Viell,W Marget,Margret Seewald,Peter Walger,R. Stuttmann,Norbert Speichermann,C. Peckelsen,Volkhard Kurowski,H.-H. Osterhues,Ljiljana Verner,R. O. Neumann,Ursula Müller‐Werdan
出处
期刊:Critical Care Medicine [Ovid Technologies (Wolters Kluwer)]
卷期号:35 (12): 2693-2701 被引量:172
标识
DOI:10.1097/01.ccm.0000295426.37471.79
摘要

Intravenous immunoglobulin as an adjunctive treatment in sepsis was regarded as promising by a Cochrane meta-analysis of smaller trials. In this phase III multicenter trial, we assessed whether intravenous immunoglobulin G (ivIgG) reduced 28-day mortality and improved morbidity in patients with score-defined severe sepsis.Randomized, double-blind, placebo-controlled, multicenter trial.Twenty-three medical and surgical intensive care units in university centers and large teaching hospitals.Patients (n = 653) with score-defined sepsis (sepsis score 12-27) and score-defined sepsis-induced severity of disease (Acute Physiology and Chronic Health Evaluation II score 20-35).Patients were assigned to receive either placebo or ivIgG (day 0, 0.6 g/kg body weight; day 1, 0.3 g/kg body weight).The prospectively defined primary end point was death from any cause after 28 days. Prospectively defined secondary end points were 7-day all-cause mortality, short-term change in morbidity, and pulmonary function at day 4. Six hundred fifty-three patients from 23 active centers formed the intention-to-treat group, 624 patients the per-protocol group (placebo group, n = 303; ivIgG group, n = 321). The 28-day mortality rate was 37.3% in the placebo group and 39.3% in the ivIgG group and thus not significantly different (p = .6695). Seven-day mortality was not reduced, and 4-day pulmonary function was not improved. Drug-related adverse events were rare in both groups. Exploratory findings revealed a 3-day shortening of mechanical ventilation in the surviving patients and no effect of ivIgG on plasma levels of interleukin-6 and tumor necrosis factor receptors I and II.In patients with score-defined severe sepsis, ivIgG with a total dose of 0.9 g/kg body weight does not reduce mortality.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
科研通AI2S应助冰冰采纳,获得10
刚刚
巫马白桃完成签到,获得积分20
3秒前
Singularity应助科研通管家采纳,获得10
3秒前
斯文败类应助科研通管家采纳,获得10
3秒前
顾矜应助科研通管家采纳,获得10
3秒前
3秒前
十二应助科研通管家采纳,获得60
3秒前
科研通AI2S应助科研通管家采纳,获得10
3秒前
4秒前
asd关闭了asd文献求助
5秒前
孟严青完成签到,获得积分10
6秒前
9秒前
烟花应助qiqi采纳,获得10
9秒前
shjyang完成签到,获得积分0
10秒前
10秒前
英俊的铭应助等待泥猴桃采纳,获得10
14秒前
15秒前
asd发布了新的文献求助10
17秒前
17秒前
edtaa完成签到 ,获得积分10
17秒前
奋斗的小熊猫完成签到 ,获得积分10
18秒前
南冥完成签到 ,获得积分10
19秒前
大勺完成签到 ,获得积分10
20秒前
22秒前
22秒前
星辰大海应助huhuhu采纳,获得10
26秒前
xiaoding应助巫马白桃采纳,获得10
28秒前
万岁发布了新的文献求助10
29秒前
咩咩羊完成签到 ,获得积分10
33秒前
36秒前
西瓜脆啵啵完成签到,获得积分20
38秒前
huhuhu发布了新的文献求助10
42秒前
46秒前
46秒前
英姑应助dxction采纳,获得10
49秒前
慕青应助123采纳,获得10
49秒前
51秒前
咩咩羊发布了新的文献求助10
52秒前
汉堡包应助huhuhu采纳,获得10
52秒前
53秒前
高分求助中
Evolution 10000
Sustainability in Tides Chemistry 2800
юрские динозавры восточного забайкалья 800
Diagnostic immunohistochemistry : theranostic and genomic applications 6th Edition 500
Chen Hansheng: China’s Last Romantic Revolutionary 500
China's Relations With Japan 1945-83: The Role of Liao Chengzhi 400
Classics in Total Synthesis IV 400
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3150395
求助须知:如何正确求助?哪些是违规求助? 2801512
关于积分的说明 7845255
捐赠科研通 2459095
什么是DOI,文献DOI怎么找? 1308964
科研通“疑难数据库(出版商)”最低求助积分说明 628618
版权声明 601727